Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Drake

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Psychopharmacology (Oxford, England)|August 23, 2008
Patient factors associated with receipt of combination antipsychotic drug therapy in the treatment of schizophreniaK P Hayhurst, R J Drake, S W Lewis
The British Journal of Psychiatry : the Journal of Mental Science|December 5, 2000
Causes and consequences of duration of untreated psychosis in schizophreniaR J Drake, C J Haley, S Akhtar, et al.
Social Psychiatry and Psychiatric Epidemiology|June 12, 2003
Health beliefs link to duration of untreated psychosis and attitudes to later treatment in early psychosisC J Haley, R J Drake, R P Bentall, et al.
Psychological Medicine|February 26, 2004
The evolution of insight, paranoia and depression during early schizophreniaR J Drake, A Pickles, R P Bentall, et al.
Psychological Medicine|August 24, 2017
The nature and efficacy of culturally-adapted psychosocial interventions for schizophrenia: a systematic review and meta-analysisA Degnan, S Baker, D Edge, et al.
Psychological Medicine|November 1, 2013
A naturalistic, randomized, controlled trial combining cognitive remediation with cognitive-behavioural therapy after first-episode non-affective psychosisR J Drake, C J Day, R Picucci, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 18, 2013
Improved quality of life over one year is associated with improved adherence in patients with schizophreniaK P Hayhurst, R J Drake, J A Massie, et al.
Molecular Psychiatry|October 5, 2016
In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [<sup>11</sup>C](R)-PK11195 positron emission tomography studyS E Holmes, R Hinz, R J Drake, et al.
Psychological Medicine|May 4, 2017
Modafinil and cognitive enhancement in schizophrenia and healthy volunteers: the effects of test battery in a randomised controlled trialJ Lees, P G Michalopoulou, S W Lewis, et al.
BMC Psychiatry|February 14, 2024
CLEAR - clozapine in early psychosis: study protocol for a multi-centre, randomised controlled trial of clozapine vs other antipsychotics for young people with treatment resistant schizophrenia in real world settingsC Casetta, P Santosh, R Bayley, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Psychopharmacology (Oxford, England)|August 23, 2008
Patient factors associated with receipt of combination antipsychotic drug therapy in the treatment of schizophreniaK P Hayhurst, R J Drake, S W Lewis
The British Journal of Psychiatry : the Journal of Mental Science|December 5, 2000
Causes and consequences of duration of untreated psychosis in schizophreniaR J Drake, C J Haley, S Akhtar, et al.
Social Psychiatry and Psychiatric Epidemiology|June 12, 2003
Health beliefs link to duration of untreated psychosis and attitudes to later treatment in early psychosisC J Haley, R J Drake, R P Bentall, et al.
Psychological Medicine|February 26, 2004
The evolution of insight, paranoia and depression during early schizophreniaR J Drake, A Pickles, R P Bentall, et al.
Psychological Medicine|August 24, 2017
The nature and efficacy of culturally-adapted psychosocial interventions for schizophrenia: a systematic review and meta-analysisA Degnan, S Baker, D Edge, et al.
Psychological Medicine|November 1, 2013
A naturalistic, randomized, controlled trial combining cognitive remediation with cognitive-behavioural therapy after first-episode non-affective psychosisR J Drake, C J Day, R Picucci, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 18, 2013
Improved quality of life over one year is associated with improved adherence in patients with schizophreniaK P Hayhurst, R J Drake, J A Massie, et al.
Molecular Psychiatry|October 5, 2016
In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [<sup>11</sup>C](R)-PK11195 positron emission tomography studyS E Holmes, R Hinz, R J Drake, et al.
Psychological Medicine|May 4, 2017
Modafinil and cognitive enhancement in schizophrenia and healthy volunteers: the effects of test battery in a randomised controlled trialJ Lees, P G Michalopoulou, S W Lewis, et al.
BMC Psychiatry|February 14, 2024
CLEAR - clozapine in early psychosis: study protocol for a multi-centre, randomised controlled trial of clozapine vs other antipsychotics for young people with treatment resistant schizophrenia in real world settingsC Casetta, P Santosh, R Bayley, et al.
Pageof 1